JOSEPH JANKOVIC to Brain
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Brain.
Connection Strength
3.324
-
Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol. 2020 06; 16(6):303-318.
Score: 0.306
-
Essential Tremor and Parkinson's Disease: Exploring the Relationship. Tremor Other Hyperkinet Mov (N Y). 2018; 8:589.
Score: 0.280
-
Dopamine transporter imaging in essential tremor with and without parkinsonian features. J Neural Transm (Vienna). 2015 Nov; 122(11):1515-21.
Score: 0.219
-
Genetics and molecular biology of brain calcification. Ageing Res Rev. 2015 Jul; 22:20-38.
Score: 0.216
-
The future of research in Parkinson disease. JAMA Neurol. 2014 Nov; 71(11):1351-2.
Score: 0.209
-
Editorial: Neurotherapeutics of movement disorders. Neurotherapeutics. 2014 Jan; 11(1):3-5.
Score: 0.197
-
Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. J Neurol Sci. 2009 Dec 15; 287(1-2):159-71.
Score: 0.147
-
Treatment of hyperkinetic movement disorders. Lancet Neurol. 2009 Sep; 8(9):844-56.
Score: 0.146
-
Clinical aspects of progressive supranuclear palsy. Handb Clin Neurol. 2008; 89:461-73.
Score: 0.130
-
Hemiparkinsonism-hemiatrophy syndrome. Neurology. 2007 Oct 16; 69(16):1585-94.
Score: 0.128
-
Genetic analysis of LRRK2 P755L variant in Caucasian patients with Parkinson's disease. Neurosci Lett. 2007 May 29; 419(2):104-7.
Score: 0.124
-
Genetic analysis of the GABRA1 gene in patients with essential tremor. Neurosci Lett. 2006 Jun 19; 401(1-2):16-9.
Score: 0.115
-
The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Prog Neurobiol. 2005 Sep-Oct; 77(1-2):128-38.
Score: 0.112
-
Neurodegenerative disease and iron storage in the brain. Curr Opin Neurol. 2004 Aug; 17(4):437-42.
Score: 0.103
-
Atypical parkinsonism and motor neuron syndrome in a Biosphere 2 participant: a possible complication of chronic hypoxia and carbon monoxide toxicity? Mov Disord. 2004 Apr; 19(4):465-9.
Score: 0.100
-
Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Mov Disord. 2004 Jan; 19(1):36-42.
Score: 0.099
-
Linking the cerebellum to Parkinson disease: an update. Nat Rev Neurol. 2023 11; 19(11):645-654.
Score: 0.097
-
Secondary dystonia following parenchymal brain tumors. J Neurol Sci. 2023 03 15; 446:120577.
Score: 0.093
-
Parkinsonism, movement disorders and genetics in frontotemporal dementia. Nat Rev Neurol. 2016 Mar; 12(3):175-85.
Score: 0.057
-
Parkinsonism and dystonia associated with adalimumab. Mov Disord. 2011 Jul; 26(8):1556-8.
Score: 0.041
-
Acquired hepatocerebral degeneration. J Neurol. 2009 Mar; 256(3):320-32.
Score: 0.035
-
Etiopathogenesis of Parkinson disease: a new beginning? Neuroscientist. 2009 Feb; 15(1):28-35.
Score: 0.035
-
Case 3, 1988. Progressive myoclonic epilepsy, dementia, and blindness in a young girl. Mov Disord. 1988; 3(4):362-9.
Score: 0.033
-
Candidate locus for chorea and tic disorders at 15q? Pediatr Neurol. 2007 Jul; 37(1):70-3.
Score: 0.031
-
Camptocormia: pathogenesis, classification, and response to therapy. Neurology. 2005 Aug 09; 65(3):355-9.
Score: 0.028
-
Searching for a relationship between manganese and welding and Parkinson's disease. Neurology. 2005 Jun 28; 64(12):2021-8.
Score: 0.027
-
Phenotypic features of Huntington's disease-like 2. Mov Disord. 2003 Dec; 18(12):1527-30.
Score: 0.025
-
Minocycline and other tetracycline derivatives: a neuroprotective strategy in Parkinson's disease and Huntington's disease. Clin Neuropharmacol. 2003 Jan-Feb; 26(1):18-23.
Score: 0.023
-
Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice. Exp Neurol. 1999 Oct; 159(2):451-8.
Score: 0.018
-
Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN). Mol Genet Genomic Med. 2019 07; 7(7):e00736.
Score: 0.018
-
Tics secondary to craniocerebral trauma. Mov Disord. 1997 Sep; 12(5):776-82.
Score: 0.016
-
[Medial posteroventral pallidotomy for the treatment of Parkinson's disease]. Zentralbl Neurochir. 1997; 58(4):153-62.
Score: 0.015
-
Surgical treatment of Parkinson's disease. Am Fam Physician. 1996 Oct; 54(5):1621-9.
Score: 0.015
-
What is it? Case 1, 1993: parkinsonism, dysautonomia, and ophthalmoparesis. Mov Disord. 1993 Oct; 8(4):525-32.
Score: 0.012
-
Chorea and ballism. Curr Opin Neurol Neurosurg. 1992 Jun; 5(3):308-13.
Score: 0.011
-
Progressive supranuclear palsy: motor, neurobehavioral, and neuro-ophthalmic findings. Adv Neurol. 1990; 53:293-304.
Score: 0.009
-
Hemiballism-hemichorea. Clinical and pharmacologic findings in 21 patients. Arch Neurol. 1989 Aug; 46(8):862-7.
Score: 0.009
-
Safety of MRI in patients with implanted deep brain stimulation devices. Neuroimage. 2009 Aug; 47 Suppl 2:T53-7.
Score: 0.009
-
Parkinsonism-plus syndromes. Mov Disord. 1989; 4 Suppl 1:S95-119.
Score: 0.009
-
Case 2, 1988. Congenital mental retardation and juvenile parkinsonism. Mov Disord. 1988; 3(4):352-61.
Score: 0.008
-
Parkinsonism and acquired hydrocephalus. Mov Disord. 1986; 1(1):59-64.
Score: 0.007
-
Microelectrode-guided posteroventral pallidotomy for treatment of Parkinson's disease: postoperative magnetic resonance imaging analysis. J Neurosurg. 1997 Sep; 87(3):358-67.
Score: 0.004
-
Posteroventral medial pallidotomy in levodopa-unresponsive parkinsonism. Arch Neurol. 1997 Aug; 54(8):1026-9.
Score: 0.004
-
Rett syndrome: controlled study of an oral opiate antagonist, naltrexone. Ann Neurol. 1994 Apr; 35(4):464-70.
Score: 0.003